ABAT vs GSK · rev $4.3M vs P/E 13, $103.31B cap
American Battery Technology Company Common Stock (ABAT) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
American Battery Technology Company Common Stock (ABAT) is a other industrial metals & mining company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ABAT revenue for 2025-06-30 was $4.3M. Net income was -$46.8M. ABAT currently screens at market cap $124.9M.
GSK does not have a complete income-statement cache yet.
ABAT currently screens at market cap $124.9M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ABAT and GSK stock pages for the full models.
Not investment advice.